Trials / Terminated
TerminatedNCT02175576
Randomized Controlled Clinical Outcomes of the Vanguard XP Bicruciate Knee System
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 50 (actual)
- Sponsor
- Zimmer Biomet · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Randomized Controlled Study to determine if preservation of ligaments provides increased functional ability post-operatively in comparison to traditional TKA which sacrifices soft tissue.
Detailed description
Randomized Controlled Study to compare clinical and patient reported outcomes of the Vanguard XP Bicruciate Total Knee System to the Vanguard CR Knee System through 10 years of follow-up.
Conditions
- Osteoarthritis
- Rheumatoid Arthritis
- Traumatic Arthritis
- Lower Limb Deformity
- Post-traumatic Deformity
- Complications, Arthroplasty
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Vanguard XP Bicruciate Knee System | The Vanguard XP is a bicruciate retaining total knee design and is constrained by natural soft tissue. |
| DEVICE | Vanguard CR Knee System | The Vanguard CR system requires the ACL to be sacrificed and is constrained by soft tissue and device design. |
Timeline
- Start date
- 2014-10-01
- Primary completion
- 2020-12-01
- Completion
- 2020-12-01
- First posted
- 2014-06-26
- Last updated
- 2023-02-21
- Results posted
- 2023-02-21
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT02175576. Inclusion in this directory is not an endorsement.